Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

Table 1 Selected patients- and disease characteristics of the total study cohort with univariable analyses of BB-CAM use

CHARACTERISTICS		ALL PATIENTS		BB-CAM				p ¹
				User		Non-user
		Total Count	% of all patients	Count	% of Total	Count	% of Total
		448	100%	332	74.1%	116	25.9%
Patients
Age in years (mean ± SD)		62.2 ± 12.4		61.5 ± 12.5		64.1 ± 12.1		0.378
	≤60 yrs.	193	43.1%	154	79.8%	39	20.2%	0.017
	>60 yrs.	255	56.9%	77	30.2%	178	69.8%	0.017
Disease								0.168
Breast-Ca	Early Stage	147	32.8%	114	77.6%	33	22.4%
	Advanced	201	44.9%	141	70.1%	60	29.9%
	Recurrence	13	2.9%	9	69.2%	4	30.8%
Ovarian-Ca	FIGO I-III	23	5.1%	21	91.3%	2	8.7%
	FIGO IV	15	3.3%	9	60.0%	6	40.0%
	Recurrence	37	8.3%	30	81.1%	7	18.9%
Other Gyn-Ca		12	2.7%	8	66.7%	4	33.3%
Disease state	Early Stage	171	38.2%	135	78.9%	36	21.1%	0.066
Disease state	Advanced+ Recurrence	277	61.8%	197	71.1%	80	28.9%	0.066

¹p values are not adjusted for multiplicity and have to be interpreted to be exploratory

ISSN: 2662-7671